Figure 4.
Therapy-induced selection of MRD clones in standard- vs high-risk MM. Suprahexagonal maps showing mutation metaclusters in black and white and changes in cellular prevalence between diagnosis and MRD tumor cells, inferred by PyClone based on detectable mutations.